跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
拜复乐 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Moxifloxacin Hydrochloride Tablets
Approved
化学药品
Moxifloxacin Hydrochloride Tablets
Bayer Vital GmbH
🇨🇳 National Medical Products Administration
Approval Date
Jun 7, 2023
Approval ID
8TEM7sjsmhG
Company
Bayer Vital GmbH
Type
化学药品
Approval Details
Approval Id
8TEM7sjsmhG
Approval Number
国药准字HJ20140721
Generic Name
盐酸莫西沙星片
Generic Name En
Moxifloxacin Hydrochloride Tablets
Trade Name
拜复乐
Drug Type
化学药品
Dosage Form
片剂
Strength
0.4g
Reg Date
2023-06-07
Expired Date
2028-06-06
Company Name
Bayer Vital GmbH
Production Company Name
BAYER HEALTHCARE MANUFACTURING SRL
Company Detail Path
/organization/bayer-vital-gmbh
Production Company Detail Path
/organization/bayer-healthcare-manufacturing-srl
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 7, 2023
Approval ID
8TEM7sjsmhG
Type
化学药品
Back to NMPA Approvals